These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22390318)

  • 1. A randomized trial investigating the efficacy and safety of water soluble micellar paclitaxel (Paccal Vet) for treatment of nonresectable grade 2 or 3 mast cell tumors in dogs.
    Vail DM; von Euler H; Rusk AW; Barber L; Clifford C; Elmslie R; Fulton L; Hirschberger J; Klein M; London C; Martano M; McNiel EA; Morris JS; Northrup N; Phillips B; Polton G; Post G; Rosenberg M; Ruslander D; Sahora A; Siegel S; Thamm D; Westberg S; Winter J; Khanna C
    J Vet Intern Med; 2012; 26(3):598-607. PubMed ID: 22390318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy and safety of a water-soluble micellar paclitaxel (Paccal Vet) in canine mastocytomas.
    Rivera P; Akerlund-Denneberg N; Bergvall K; Kessler M; Rowe A; Willmann M; Persson G; Kastengren Fröberg G; Westberg S; von Euler H
    J Small Anim Pract; 2013 Jan; 54(1):20-7. PubMed ID: 23190121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II clinical trial of vinorelbine in dogs with cutaneous mast cell tumors.
    Grant IA; Rodriguez CO; Kent MS; Sfilgoi G; Gordon I; Davis G; Lord L; London CA
    J Vet Intern Med; 2008; 22(2):388-93. PubMed ID: 18312556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dose-finding study with a novel water-soluble formulation of paclitaxel for the treatment of malignant high-grade solid tumours in dogs.
    von Euler H; Rivera P; Nyman H; Häggström J; Borgå O
    Vet Comp Oncol; 2013 Dec; 11(4):243-55. PubMed ID: 22404965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of canine mast cell tumors with CCNU (lomustine).
    Rassnick KM; Moore AS; Williams LE; London CA; Kintzer PP; Engler SJ; Cotter SM
    J Vet Intern Med; 1999; 13(6):601-5. PubMed ID: 10587263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant CCNU (lomustine) and prednisone chemotherapy for dogs with incompletely excised grade 2 mast cell tumors.
    Hosoya K; Kisseberth WC; Alvarez FJ; Lara-Garcia A; Beamer G; Stromberg PC; Couto CG
    J Am Anim Hosp Assoc; 2009; 45(1):14-8. PubMed ID: 19122059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012).
    Lejeune A; Skorupski K; Frazier S; Vanhaezebrouck I; Rebhun RB; Reilly CM; Rodriguez CO
    Vet Comp Oncol; 2015 Sep; 13(3):267-80. PubMed ID: 23721492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision.
    London CA; Malpas PB; Wood-Follis SL; Boucher JF; Rusk AW; Rosenberg MP; Henry CJ; Mitchener KL; Klein MK; Hintermeister JG; Bergman PJ; Couto GC; Mauldin GN; Michels GM
    Clin Cancer Res; 2009 Jun; 15(11):3856-65. PubMed ID: 19470739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effects of the chemotherapy agent water-soluble micellar paclitaxel (Paccal Vet) on canine hemangiosarcoma cell lines.
    Reckelhoff CR; Lejeune A; Thompson PM; Shiomitsu K
    Vet Comp Oncol; 2019 Mar; 17(1):32-41. PubMed ID: 30267450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs.
    Burton JH; Venable RO; Vail DM; Williams LE; Clifford CA; Axiak-Bechtel SM; Avery AC; Thamm DH
    J Vet Intern Med; 2015; 29(4):1098-104. PubMed ID: 26119008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vincristine therapy for mast cell tumors in dogs.
    McCaw DL; Miller MA; Bergman PJ; Withrow SJ; Moore AS; Knapp DW; Fowler D; Johnson JC
    J Vet Intern Med; 1997; 11(6):375-8. PubMed ID: 9470165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours.
    Rassnick KM; Bailey DB; Russell DS; Flory AB; Kiselow MA; Intile JL; Malone EK; Balkman CE; Barnard SM
    Vet Comp Oncol; 2010 Jun; 8(2):138-52. PubMed ID: 20579327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lomustine for the treatment of gastrointestinal mast cell tumour in a dog.
    Baldi A; Colloca E; Spugnini EP
    J Small Anim Pract; 2006 Aug; 47(8):465-7. PubMed ID: 16911116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors.
    Carlsten KS; London CA; Haney S; Burnett R; Avery AC; Thamm DH
    J Vet Intern Med; 2012; 26(1):135-41. PubMed ID: 22176473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features and outcome for dogs with mast cell tumors and bone marrow involvement.
    Marconato L; Bettini G; Giacoboni C; Romanelli G; Cesari A; Zatelli A; Zini E
    J Vet Intern Med; 2008; 22(4):1001-7. PubMed ID: 18564225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases.
    Taylor F; Gear R; Hoather T; Dobson J
    J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of oral paclitaxel for the treatment of bladder tumors in dogs.
    Chae HK; Yang JI; An JH; Lee IH; Son MH; Song WJ; Youn HY
    J Vet Med Sci; 2020 May; 82(5):527-530. PubMed ID: 32249251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypotonic water as adjuvant therapy for incompletely resected canine mast cell tumors: a randomized, double-blind, placebo-controlled study.
    Brocks BA; Neyens IJ; Teske E; Kirpensteijn J
    Vet Surg; 2008 Jul; 37(5):472-8. PubMed ID: 18986315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors.
    Hahn KA; Legendre AM; Shaw NG; Phillips B; Ogilvie GK; Prescott DM; Atwater SW; Carreras JK; Lana SE; Ladue T; Rusk A; Kinet JP; Dubreuil P; Moussy A; Hermine O
    Am J Vet Res; 2010 Nov; 71(11):1354-61. PubMed ID: 21034327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisone and vinblastine chemotherapy for canine mast cell tumor--41 cases (1992-1997).
    Thamm DH; Mauldin EA; Vail DM
    J Vet Intern Med; 1999; 13(5):491-7. PubMed ID: 10499735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.